Association of Hyperautofluorescence Signals with Geographic Atrophy Progression in the METforMIN Trial
-
Published:2024-09
Issue:
Volume:
Page:100620
-
ISSN:2666-9145
-
Container-title:Ophthalmology Science
-
language:en
-
Short-container-title:Ophthalmology Science
Author:
Taha Abu Tahir,
Shen Liangbo Linus,
Diaz Antonio,
Chahal Noor,
Saroya Jasmeet,
Sun Mengyuan,
Allingham Michael J.,
Farsiu Sina,
Yiu Glenn,
Keenan Jeremy D.,
Stewart Jay M.ORCID
Reference86 articles.
1. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob Health,2014
2. HISTOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Multilayer Approach;Li;Retina Phila Pa,2018
3. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial;Khanani;Lancet Lond Engl,2023
4. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials;Heier;Lancet Lond Engl,2023
5. Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration;Khan;Clin Ophthalmol Auckl NZ,2023